CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor

Guiqi Zhu, Zheng Tang, Run Huang, +17

Cell Discovery

An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte–tumor cell crosstalk, local immunosuppression and tumor progression

Liang Wu, Jiayan Yan, Yinqi Bai, +50

Cell Research

Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing

Xiaowei Chen, Haixiang Sun, Fei Jiang, +5

PeerJ

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Yuan Fang, Weiren Liu, Zheng Tang, +22

Hepatology

Up-regulation of Krüppel-Like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma

Jiachu Li, Xin‐Rong Yang, Haixiang Sun, +9

Gastroenterology

Tumor BiologyHepatologyPromotes Tumor InvasionMedicinePathology +7

Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma

Rui Peng, Pengfei Zhang, Xuan Yang, +11

Journal of Experimental & Clinical Cancer Research

Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma

Nan Xie, Jiabin Cai, Lu Zhang, +16

Cell Death and Disease

circRNA circMED27 acts as a prognostic factor and mediator to promote lenvatinib resistance of hepatocellular carcinoma

Pengfei Zhang, Haixiang Sun, Peihao Wen, +3

Molecular Therapy — Nucleic Acids

Lenvatinib ResistanceOncologyHcc SerumCircular RnasHcc Resistance +13

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study

Guiqi Zhu, Weiren Liu, Zheng Tang, +16

Molecular Oncology

Surgical OncologyCtdna PositivityTumor RecurrencePathologyTumor Biology +14

Long non-coding RNA00364 represses hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2 signaling axis

Wei‐Guo Tang, Bo Hu, Haixiang Sun, +9

Oncotarget